Stilnox 12.5 mg MR Tablet
PDF Leaflet Revision Date: 15 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of severe insomnia in adults under 65.
Dosage (summary)
12.5 mg orally before bedtime; max 12.5 mg, not to be readministered the same night.
Onset of Action / Duration
Onset: Rapid, Duration: 4-8 hours
Special Populations
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Avoid in pregnancy; not recommended during lactation.
Key Drug Interactions
- Alcohol
- CNS depressants
- Opioids
- CYP450 inhibitors
Contraindications
- Hypersensitivity to zolpidem
- Children under 18
- Severe hepatic impairment
- Sleep apnoea
- Myasthenia gravis
Common side effects
- Headache
- Dizziness
- Somnolence
- Nausea
- Fatigue
Counselling Points
- Take immediately before bed
- Avoid alcohol
- Do not drive after use
- Report unusual behaviors
Serious warnings
- Risk of dependence
- Amnesia
- Respiratory depression
- Suicidality
Important Disclaimer
The Stilnox 12.5 mg MR Tablet professional information leaflet below is the property of Sanofi-Aventis South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
